FDA label
What is Alrex used for?
Alrex contains loteprednol etabonate. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “ALREX ophthalmic suspension is indicated for the temporary relief of the signs and symptoms of seasonal allergic conjunctivitis.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Alrex?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Alrex, suspension/ drops
Indications and Usage, quoted from the label by Bausch & Lomb Incorporated (NDA020803). Cross-references to other label sections are left out.
ALREX ophthalmic suspension is indicated for the temporary relief of the signs and symptoms of seasonal allergic conjunctivitis.
Source: DailyMed label, set id 21c76da0-50a1-41c0-91b8-8cc4dcc27f60, version 14, effective March 31, 2022. NDC 24208-353, one of 1 listing for this product.
Questions
What is Alrex used for?
The FDA label says: “ALREX ophthalmic suspension is indicated for the temporary relief of the signs and symptoms of seasonal allergic conjunctivitis.”
What drug class is Alrex?
FDA lists loteprednol etabonate in the Corticosteroid established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Alrex
- Is Alrex a controlled substance?Federal schedule
- Generic for AlrexFDA Orange Book
- What is Loteprednol Etabonate used for?FDA label uses
- Is Loteprednol Etabonate a controlled substance?Federal schedule
- Generic for LotemaxFDA Orange Book
- Generic for Lotemax SMFDA Orange Book
- Generic for EysuvisFDA Orange Book
- Generic for InveltysFDA Orange Book
- Corticosteroids listFDA drug class
- NDC 24208-353Alrex NDC record